[Show abstract][Hide abstract] ABSTRACT: This paper discusses the nature of genomic information, and the moral arguments in support of an individual's right to access
it. It analyses the legal avenues an individual might take to access their sequence information. The authors describe the
policy implications in this area and conclude that, for now, the law appears to strike an appropriate balance, but new policy
will need to be developed to address this issue.
Full-text · Article · Oct 2013 · Medical Law Review
[Show abstract][Hide abstract] ABSTRACT: Consent forms are the principal method for obtaining informed consent from biomedical research participants. The significance of these forms is increasing as more secondary research is undertaken on existing research samples and information, and samples are deposited in biobanks accessible to many researchers. We reviewed a selection of consent forms used in European Genome-Wide Association Studies (GWAS) and identified four common elements that were found in every consent form. Our analysis showed that only two of the four most commonly found elements in our sample of informed consent forms were required in UK law. This raises questions about what should be put in informed consent forms for research participants. These findings could be beneficial for the formulation of participant information and consent documentation in the future studies.
Full-text · Article · Dec 2011 · European Journal of Health Law
[Show abstract][Hide abstract] ABSTRACT: Analyses of individuals' genomes--their entire DNA sequence--have increased knowledge about the links between genetics and disease. Anticipated advances in 'next generation' DNA-sequencing techniques will see the routine research use of whole genomes, rather than distinct parts, within the next few years. The scientific benefits of genomic research are, however, accompanied by legal and ethical concerns. Despite the assumption that genetic research data can and will be rendered anonymous, participants' identities can sometimes be elucidated, which could cause data protection legislation to apply. We undertake a timely reappraisal of these laws--particularly new penalties--and identifiability in genomic research.
Full-text · Article · Sep 2010 · European Journal of Health Law